CONSULTING AGREEMENTConsulting Agreement • August 5th, 2021 • Aligos Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This CONSULTING Agreement is made and entered into as of June 17, 2021 (the “Effective Date”) by and between Aligos Therapeutics, Inc., a Delaware corporation having a principal place of business at 1 Corporate Drive, 2nd Floor, South San Francisco, CA 94080 (“Aligos”) and Kathleen Sereda Glaub, an individual with an address of 1050 Lee Avenue, San Leandro, CA 94577 (“Consultant”). Aligos and the Consultant may be referred to herein individually as “Party” or collectively, as “Parties.”
